Sangamo Therapeutics Announces Participation In The Bank Of America Merrill Lynch 2019 Health Care Conference

May 10, 2019 at 8:30 AM EDT

BRISBANE, Calif., May 10, 2019 /PRNewswire/ -- Sangamo Therapeutics, Inc. (NASDAQ: SGMO) announced today that Sangamo will participate in the Bank of America Merrill Lynch 2019 Health Care Conference being held next week in Las Vegas. A "fireside chat" discussion with Sangamo CEO Sandy Macrae is scheduled for Tuesday, May 14th at 5 p.m. PT.

Sangamo Therapeutics, Inc. (PRNewsfoto/Sangamo Therapeutics, Inc.)

The discussion will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The event will be archived on the Sangamo website for two weeks after the event.

About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, ex vivo gene-edited cell therapy, in vivo genome editing, and gene regulation. For more information about Sangamo, visit www.sangamo.com.

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-participation-in-the-bank-of-america-merrill-lynch-2019-health-care-conference-300847811.html

SOURCE Sangamo Therapeutics, Inc.

Investors: McDavid Stilwell, 510-970-6000, x219, mstilwell@sangamo.com